Ala-Acv-Ct014
ClinicalTrials.gov NCT05080764
Research payments
$1,102,018
Through program year 2024, $1,102,018 in research payments was reported against Ala-Acv-Ct014, across 68 payments, paid by Biofrontera Bioscience GmbH.
- Paid by
- Biofrontera Bioscience GmbH
- ClinicalTrials.gov
- NCT05080764
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $521,515 | 48 |
| 2023 | Research | $460,308 | 14 |
| 2022 | Research | $120,195 | 6 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ira Thorla Baton Rouge, LA Named on 17 payments
- Janet DuBois Austin, TX Named on 16 payments
- Mitchel Goldman San Diego, CA Named on 8 payments
- Edward Lain Pflugerville, TX Named on 7 payments
- Seth Forman Tampa, FL Named on 6 payments
- John Tu Rochester, NY Named on 4 payments
- Todd Schlesinger Charleston, SC Named on 4 payments
- Vivian Laquer Fountain Valley, CA Named on 3 payments
- Andrea Zaenglein Hershey, PA Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.